These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7183581)

  • 21. The pharmacology of antirheumatic drugs.
    Parnham MJ
    Agents Actions Suppl; 1984; 14():153-69. PubMed ID: 6382972
    [No Abstract]   [Full Text] [Related]  

  • 22. Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold.
    Paulus HE; Williams HJ; Ward JR; Reading JC; Egger MJ; Coleman ML; Samuelson CO; Willkens RF; Guttadauria M; Alarcón GS
    Arthritis Rheum; 1984 Jul; 27(7):721-7. PubMed ID: 6378208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Critical evaluation of rheumatism therapy. Basic drugs].
    Meyer W
    Ther Ggw; 1975 Dec; 114(12):2029-42. PubMed ID: 1198356
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparison of therapeutic effects of various immunosuppressive drugs in rheumatoid arthritis].
    Bogdanikowa B; Bernacka K; Rudy J; Stasiewicz A
    Pol Arch Med Wewn; 1973; 50(10):1019-25. PubMed ID: 4757602
    [No Abstract]   [Full Text] [Related]  

  • 25. Do drugs change the course of rheumatoid arthritis?
    Wright V; Amos R
    Br Med J; 1980 Apr; 280(6219):964-6. PubMed ID: 6106520
    [No Abstract]   [Full Text] [Related]  

  • 26. Two cases of penicillamine-induced pemphigus erythematosus.
    Thorvaldsen J
    Dermatologica; 1979; 159(2):167-70. PubMed ID: 157890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interim observations on benefit/risk of azathioprine versus D-penicillamine in the treatment of rheumatoid arthritis.
    Ward JR; Williams HJ
    Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):23-5. PubMed ID: 6802080
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical aspects: specificity and mode of action of immunosuppressives.
    Currey HL
    Rheumatol Rehabil; 1976 Aug; 15(3):221-3. PubMed ID: 9683
    [No Abstract]   [Full Text] [Related]  

  • 29. Limited plasmapheresis in rheumatoid arthritis with vasculitis.
    Goldman JA; Casey HL; McIlwain H; Kirby J; Wilson CH; Miller SB
    Arthritis Rheum; 1979 Oct; 22(10):1146-50. PubMed ID: 39566
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chlorbutin, azathioprine, D-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis. Comparative analysis of their effect on the indices of disease activity and progression].
    Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV
    Ter Arkh; 1982; 54(6):82-92. PubMed ID: 7112429
    [No Abstract]   [Full Text] [Related]  

  • 31. A longitudinal study of pulmonary function in patients with rheumatoid arthritis treated with gold and D-penicillamine.
    Chakravarty K; Webley M
    Br J Rheumatol; 1992 Dec; 31(12):829-33. PubMed ID: 1458289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold.
    Huskisson EC; Berry H
    Postgrad Med J; 1974 Aug; 50 Suppl 2():59-61. PubMed ID: 4467180
    [No Abstract]   [Full Text] [Related]  

  • 33. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Pincus T; Callahan LF
    Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
    Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S
    Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid arthritis therapy: the slow-acting agents.
    Hardin JG
    Hosp Pract (Off Ed); 1989 Jun; 24(6):163-8, 170, 173-8. PubMed ID: 2566617
    [No Abstract]   [Full Text] [Related]  

  • 37. Double-blind trial of levamisole, penicillamine and azathioprine in rheumatoid arthritis. Clinical, biochemical, radiological and scintigraphic studies.
    Halberg P; Bentzon MW; Crohn O; Gad I; Halskov O; Heyn J; Ingemann M; Junker P; Lorenzen I; Møller I
    Dan Med Bull; 1984 Oct; 31(5):403-9. PubMed ID: 6391849
    [No Abstract]   [Full Text] [Related]  

  • 38. Controlled, double-blind, comparative studies of disease modifying anti-rheumatic drugs in the treatment of patients with rheumatoid arthritis. A review.
    Halberg P
    Dan Med Bull; 1984 Oct; 31(5):391-402. PubMed ID: 6391848
    [No Abstract]   [Full Text] [Related]  

  • 39. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A trial of comparative effects of gold salts and D-penicillamine in rheumatoid arthritis].
    Nezić-Ivković J; Dürrigl T
    Reumatizam; 1978; 25(3):75-8. PubMed ID: 353935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.